Nelson DR - Search Results

1

The protein C pathway: implications for the design of the RESPOND study.

Vangerow B, Shorr AF, Wyncoll D, Janes J, Nelson DR, Reinhart K. Vangerow B, et al. Among authors: nelson dr. Crit Care. 2007;11 Suppl 5(Suppl 5):S4. doi: 10.1186/cc6155. Crit Care. 2007. PMID: 18269691 Free PMC article. Review.

2

Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcome.

Shorr AF, Bernard GR, Dhainaut JF, Russell JR, Macias WL, Nelson DR, Sundin DP. Shorr AF, et al. Among authors: nelson dr. Crit Care. 2006;10(3):R92. doi: 10.1186/cc4946. Epub 2006 Jun 15. Crit Care. 2006. PMID: 16780598 Free PMC article. Clinical Trial.

3

Protein C: a potential biomarker in severe sepsis and a possible tool for monitoring treatment with drotrecogin alfa (activated).

Shorr AF, Nelson DR, Wyncoll DL, Reinhart K, Brunkhorst F, Vail GM, Janes J. Shorr AF, et al. Among authors: nelson dr. Crit Care. 2008;12(2):R45. doi: 10.1186/cc6854. Epub 2008 Apr 4. Crit Care. 2008. PMID: 18394162 Free PMC article. Review.

4

Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure.

Dhainaut JF, Shorr AF, Macias WL, Kollef MJ, Levi M, Reinhart K, Nelson DR. Dhainaut JF, et al. Among authors: nelson dr. Crit Care Med. 2005 Feb;33(2):341-8. doi: 10.1097/01.ccm.0000153520.31562.48. Crit Care Med. 2005. PMID: 15699837

5

Lack of evidence for qualitative treatment by disease severity interactions in clinical studies of severe sepsis.

Macias WL, Nelson DR, Williams M, Garg R, Janes J, Sashegyi A. Macias WL, et al. Among authors: nelson dr. Crit Care. 2005;9(6):R607-22. doi: 10.1186/cc3795. Epub 2005 Sep 22. Crit Care. 2005. PMID: 16280057 Free PMC article. Review.

6

Drotrecogin alfa (activated): current evidence supports treatment for severe sepsis patients with a high risk of death.

Williams MD, Janes JM, Nelson DR. Williams MD, et al. Among authors: nelson dr. Crit Care. 2006;10(5):424. doi: 10.1186/cc5062. Crit Care. 2006. PMID: 17094791 Free PMC article. No abstract available.

7

Influence of enrollment sequence effect on observed outcomes in the ADDRESS and PROWESS studies of drotrecogin alfa (activated) in patients with severe sepsis.

Laterre PF, Macias WL, Janes J, Williams MD, Nelson DR, Girbes AR, Dhainaut JF, Abraham E. Laterre PF, et al. Among authors: nelson dr. Crit Care. 2008;12(5):R117. doi: 10.1186/cc7011. Epub 2008 Sep 11. Crit Care. 2008. PMID: 18786266 Free PMC article.

8

Sources of variability on the estimate of treatment effect in the PROWESS trial: implications for the design and conduct of future studies in severe sepsis.

Macias WL, Vallet B, Bernard GR, Vincent JL, Laterre PF, Nelson DR, Derchak PA, Dhainaut JF. Macias WL, et al. Among authors: nelson dr. Crit Care Med. 2004 Dec;32(12):2385-91. doi: 10.1097/01.ccm.0000147440.71142.ac. Crit Care Med. 2004. PMID: 15599140 Clinical Trial.

9

A registry of patients treated with drotrecogin alfa (activated) in Belgian intensive care units--an observational study.

Vincent JL, Laterre PF, Decruyenaere J, Spapen H, Raemaekers J, Damas F, Rogiers P, Sartral M, Haentjens T, Nelson D, Janes J. Vincent JL, et al. Acta Clin Belg. 2008 Jan-Feb;63(1):25-30. doi: 10.1179/acb.2008.004. Acta Clin Belg. 2008. PMID: 18386762

10

Underlying disorders and their impact on the host response to infection.

Dhainaut JF, Claessens YE, Janes J, Nelson DR. Dhainaut JF, et al. Among authors: nelson dr. Clin Infect Dis. 2005 Nov 15;41 Suppl 7:S481-9. doi: 10.1086/432001. Clin Infect Dis. 2005. PMID: 16237651 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

937 results

Search Page

Filters